Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


AZ vax first up to TGA

Posted 12 October 2020

AstraZeneca has become the first company to be granted provisional determination for a COVID-19 vaccine in Australia, putting the Oxford University recombinant candidate on track for local arrival in the first quarter of 2021.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Special Report
Aust Covid Vaccine Tracker
UPDATES: UNICEF stockpiling one billion syringes
Approvals Action
Shakeup for insulin
New biosim plus hypertension and herpes generics
Top of the Hill
Avoiding the Emperor's mistake
Not everyone is convinced about industry's budget win